SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000926617-21-000039
Filing Date
2021-04-30
Accepted
2021-04-30 17:02:30
Documents
3
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A awh-20201231x10ka.htm 10-K/A 754820
2 EX-31.1 awh-20201231xex31_1.htm EX-31.1 6113
3 EX-31.2 awh-20201231xex31_2.htm EX-31.2 6172
  Complete submission text file 0000926617-21-000039.txt   768457
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34810 | Film No.: 21879370
SIC: 2835 In Vitro & In Vivo Diagnostic Substances